NexImmune

(OTC) NEXI

Current Price$0.00

Market Cap$100.00

Since IPO (2021)-100%

5 Year-100%

1 Year+0%

1 Month+0%

NexImmune Financials at a Glance

Market Cap

$100.00

Revenue (TTM)

$2.12M

Net Income (TTM)

-$20.62M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

117693.72 (High)

Dividend

$0.00

Beta (Volatility)

117693.72 (High)

Price

$0.00

Volume

186

Open

$0.00

Price

$0.00

Volume

186

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $2.17

Estimated Earnings Date

Aug 14, 2026

Dividend

$0.00

Beta (Volatility)

117693.72 (High)

Price

$0.00

Volume

186

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $2.17

Estimated Earnings Date

Aug 14, 2026

NEXI News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About NexImmune

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Kristi Jones

Website

www.neximmune.com

Headquarters

Gaithersburg, MD 20877, US

NEXI Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

-8%

Return on Assets

-4%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$100.00

Shares Outstanding

1.39M

Volume

186

Avg. Volume

218.75

Financials (TTM)

Gross Profit

-$1.02M

Operating Income

-$29.19M

EBITDA

-$28.17M

Operating Cash Flow

-$31.43M

Capital Expenditure

-$48.72K

Free Cash Flow

-$31.48M

Cash & ST Invst.

$4.65M

Total Debt

$68.81K

NexImmune Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2024YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$75.41K

+81.2%

Gross Margin

0.00%

N/A

Market Cap

$100.00

N/A

Market Cap/Employee

$16.67

N/A

Employees

N/A

Net Income

-$2.33M

+69.2%

EBITDA

-$2.65M

+63.3%

Quarterly Fundamentals

Name

Q2 2024YOY CHG

Total Cash

$2.42M

-85.1%

Total Debt

$0.00

-100.0%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

-100.0%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$0.00

-100.0%

Return on Assets

-3.76%

N/A

Return on Invested Capital

-8.32%

N/A

Free Cash Flow

-$2.07M

+65.7%

Operating Cash Flow

-$2.07M

+65.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

MDVLQMedAvail Holdings, Inc.

MDVLQMedAvail Holdings, Inc.$0.00+0.00%

HTGMQHTG Molecular Diagnostics, Inc.

HTGMQHTG Molecular Diagnostics, Inc.$0.00+0.00%

BSPMBiostar Pharmaceuticals, Inc.

BSPMBiostar Pharmaceuticals, Inc.$0.00+0.00%

OMDDOrmand Industries Inc

OMDDOrmand Industries Inc$0.00+0.00%

NBRVFNabriva Therapeutics plc

NBRVFNabriva Therapeutics plc$0.00+0.00%

BIOCQBiocept, Inc.

BIOCQBiocept, Inc.$0.00+0.00%

NMSCANutrition Management Services Company

NMSCANutrition Management Services Company$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$14.98+0.02%

NOKNokia

NOKNokia$14.80+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.02-0.00%

ASTSAST SpaceMobile

ASTSAST SpaceMobile$82.41-0.16%

Questions About NEXI

What is the current price of NexImmune?

NexImmune is trading at $0.00 per share.

What is the 52-week range for NexImmune?

Over the past 52 weeks, NexImmune has traded between $0.00 and $2.17.

How much debt does NexImmune have?

As of the most recent reporting period, NexImmune reported total debt of $0.00.

How much cash does NexImmune have on hand?

NexImmune reported $2.44M in cash and cash equivalents in its most recent financial results.

What is NexImmune’s dividend yield?

NexImmune does not currently have a dividend yield.

NexImmune

NexImmune Financials at a Glance

NEXI News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About NexImmune

NEXI Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

NexImmune Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About NEXI

What is the current price of NexImmune?

What is the 52-week range for NexImmune?

How much debt does NexImmune have?

How much cash does NexImmune have on hand?

What is NexImmune’s dividend yield?

Premium Investing Services